Rare case of aggressive systemic mastocytosis identified in newborn
A new case study from New Zealand sheds light on diagnostic and treatment challenges for aggressive systemic mastocytosis in newborns
All articles by Ashley Welch
-
-
Adding to your toolkit: Helpful apps for people with systemic mastocytosis
There are a number of apps with tools helpful for patients with SM.
-
Rethinking the bone marrow: Study calls for new focus in treating SM
A new review urges researchers to take a closer look at the bone marrow microenvironment when considering future treatment for SM.
-
Study underscores link between hymenoptera allergy and mast cell disorders
New research highlights the link between clonal mast cell diseases like SM and severe systemic reactions to certain insect stings.
-
New data shows long-term benefits of avapritinib for people living with SM
Updated data shows sustained clinical efficacy and tolerance of Ayvakit (avapritinib) treatment for systemic mastocytosis.
-
Study finds rising incidence and cancer risk in US systemic mastocytosis cases
New study reveals rising U.S. rates of systemic mastocytosis and increased risk of secondary cancers, especially in older adults.
-
Researchers call for more individualized testing to diagnose systemic mastocytosis
Relying on BST levels to diagnose SM doesn’t account for individual variability influenced by genetic and physiological factors.
-
Current and future therapy options for systemic mastocytosis
Several newly approved and experimental treatments have shown promise in the management of systemic mastocytosis.
-
Genetic trait may heighten anaphylaxis risk for people with SM
A genetic trait that increases risk of anaphylaxis is higher in people with SM. Identifying the trait early could mean better treatment.
-
Targeted therapy brings rapid remission in child with SM-associated leukemia
The targeted therapy drug gemtuzumab ozogamicin successfully treated a young boy with SM-AHN who did not respond to conventional therapies.
